Acquisition and Decay of Antibodies to Pregnancy‐Associated Variant Antigens on the Surface of Plasmodium falciparum–Infected Erythrocytes That Protect against Placental Parasitemia
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Otherwise clinically immune women in areas endemic for malaria are highly susceptible to Plasmodium falciparum malaria during their first pregnancy. Pregnancy-associated malaria (PAM) is characterized by placental accumulation of infected erythrocytes that adhere to chondroitin sulfate A (CSA). Susceptibility to PAM decreases with increasing parity, apparently due to acquisition of antibodies directed against the variant surface antigens (VSAs) that mediate the adhesion to CSA (VSA(CSA)). This study found that levels of VSA(CSA)-specific antibodies depend on endemicity, that anti-VSA(CSA) IgG is acquired during gestation week 20, and that plasma levels of the antibodies decline during the postpartum period. There is evidence that VSA(CSA)-specific antibodies are linked to placental infection and that high antibody levels contribute to the control of placental infection by inhibiting parasite adhesion to CSA. Data suggest that VSA(CSA) is a target for vaccination against PAM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is sex specific because men from malaria-endemic areas do not develop VSAPAM antibodies”
From Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria (2004) · cites this paper as [4]
In the citing paper
“Parasites causing PAM express unique VSA types, VSAPAM, which can be serologically classified as sex specific and parity dependent.”
From Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria (2004) · cites this paper as [4]
In the citing paper
“it is parity dependent because women acquire anti-VSAPAM immunoglobulin (Ig) G as a function of parity.”
From Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria (2004) · cites this paper as [4]
Citations
Cites
Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta
Fried, M., & Duffy, P. E. (1996) · Science · doi:10.1126/science.272.5267.1502 · Cited by 1,108
An analysis of malaria in pregnancy in Africa.
Brabin, B. J. (1983) · PubMed · Cited by 782
Maternal antibodies block malaria
Fried, M., Nosten, F., Brockman, A., Brabin, B. J., & Duffy, P. E. (1998) · Nature · doi:10.1038/27570 · Cited by 659
Snounou, G., Zhu, X., Siripoon, N., Jarra, W., Thaithong, S., Brown, K. N., & Viriyakosol, S. (1999) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(99)90120-7 · Cited by 546
Antigens Induced on Erythrocytes by P. falciparum : Expression of Diverse and Conserved Determinants
Marsh, K., & Howard, R. J. (1986) · Science · doi:10.1126/science.2417315 · Cited by 322
Fried, M., Muga, R., Misore, A. O., & Duffy, P. E. (1998) · PubMed · Cited by 321
Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria
Beeson, J. G., Rogerson, S. J., Cooke, B. M., Reeder, J. C., Chai, W., Lawson, A. M., Molyneux, M. E., & Brown, G. V. (2000) · Nature Medicine · doi:10.1038/71582 · Cited by 310
Ricke, C. H., Staalsoe, T., Koram, K., Akanmori, B. D., Riley, E. M., Theander, T. G., & Hviid, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3309 · Cited by 303
Self-citationBeeson, J. G., Brown, G. V., Molyneux, M. E., Mhango, C., Dzinjalamala, F., & Rogerson, S. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/314899 · Cited by 266
Reeder, J. C., Cowman, A. F., Davern, K. M., Beeson, J. G., Thompson, J. K., Rogerson, S. J., & Brown, G. V. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5198 · Cited by 252
Cited by
Salanti, A., Staalsoe, T., Lavstsen, T., Jensen, A. T. R., Sowa, M. P. K., Arnot, D. E., Hviid, L., & Theander, T. G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03570.x · Cited by 702
“…1), and the VSA-specific antibodies mediating this recognition block parasite adhesion to CSA in vitro (Fried et al., 1998; Ricke et al., 2000) and are associated with protection from placental parasitaemia, maternal anaemia and low birthweight in vivo (Staalsoe et al., 2001; our unpublished data).”
BackgroundMethodSelf-citationMalaria in pregnancy: pathogenesis and immunity
Rogerson, S. J., Hviid, L., Duffy, P. E., Leke, R. F., & Taylor, D. W. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70022-1 · Cited by 628
Self-citationEvidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria
Salanti, A., Dahlbäck, M., Turner, L., Nielsen, M. A., Barfod, L., Magistrado, P., Jensen, A. T. R., Lavstsen, T., Ofori, M. F., Marsh, K., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041579 · Cited by 604
“PAM is characterized by placental accumulation of parasiteinfected erythrocytes (IEs), which are unusual in being able to bind to chondroitin sulfate A (CSA) in vitro (2) and in not being recognized by IgG in the plasma of malaria-exposed men who have IgG with specificity for IEs infecting nonpregnant individuals (3,…”
BackgroundMethodSelf-citationImmune effector mechanisms in malaria
MARSH, K., & KINYANJUI, S. (2006) · Parasite Immunology · doi:10.1111/j.1365-3024.2006.00808.x · Cited by 419
Staalsoe, T., Shulman, C. E., Bulmer, J. N., Kawuondo, K., Marsh, K., & Hviid, L. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15386-x · Cited by 288
Self-citationRobinson, B. A., Welch, T. L., & Smith, J. D. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03378.x · Cited by 204
Nielsen, M. A., Staalsoe, T., Kurtzhals, J. A. L., Goka, B. Q., Dodoo, D., Alifrangis, M., Theander, T. G., Akanmori, B. D., & Hviid, L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3444 · Cited by 207
Self-citationFried, M., & Duffy, P. E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025551 · Cited by 202
“…that surface-react are higher in multigravidae compared with primigravidae in many different countries (Fried et al. 1998a; Ricke et al. 2000; Staalsoe et al. 2001, 2004; Tuikue Ndam et al. 2004; Megnekou et al. 2005; Fievet et al. 2006; Feng et al. 2009; Aitken et al. 2010; Mayor et al.…”
InfluentialMalaria in pregnancy and the endemicity spectrum: what can we learn?
Nosten, F., Rogerson, S. J., Beeson, J. G., McGready, R., Mutabingwa, T. K., & Brabin, B. (2004) · Trends in Parasitology · doi:10.1016/j.pt.2004.06.007 · Cited by 186
Chang, C. C., Crane, M., Zhou, J., Mina, M., Post, J. J., Cameron, B. A., Lloyd, A. R., Jaworowski, A., French, M. A., & Lewin, S. R. (2013) · Immunological Reviews · doi:10.1111/imr.12063 · Cited by 163
“Development of anti-VAR2CSA antibodies mainly occurs in the second trimester of pregnancy and increases with the number of pregnancies (289, 290, 311, 312).”
BackgroundHigh Level of var2csa Transcription by Plasmodium falciparum Isolated from the Placenta
Tuikue Ndam, N. G., Salanti, A., Bertin, G., Dahlbäck, M., Fievet, N., Turner, L., Gaye, A., Theander, T., & Deloron, P. (2005) · The Journal of Infectious Diseases · doi:10.1086/430933 · Cited by 179
“The serological phenotype of PAM parasites is also distinct, because, in areas where malaria is endemic, anti-VSAPAM IgG is not present in men and is acquired in a parity-dependant fashion in women [4].”
Self-citationTrimnell, A. R., Kraemer, S. M., Mukherjee, S., Phippard, D. J., Janes, J. H., Flamoe, E., Su, X.-Z., Awadalla, P., & Smith, J. D. (2006) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2006.03.012 · Cited by 165
Naturally acquired immunity to Plasmodium falciparum malaria in Africa
Hviid, L. (2005) · Acta Tropica · doi:10.1016/j.actatropica.2005.06.012 · Cited by 163
Self-citationMalaria-Induced Acquisition of Antibodies to Plasmodium falciparum Variant Surface Antigens
Ofori, M. F., Dodoo, D., Staalsoe, T., Kurtzhals, J. A. L., Koram, K., Theander, T. G., Akanmori, B. D., & Hviid, L. (2002) · Infection and Immunity · doi:10.1128/iai.70.6.2982-2988.2002 · Cited by 134
Self-citationSpecific Receptor Usage in Plasmodium falciparum Cytoadherence Is Associated with Disease Outcome
Ochola, L. B., Siddondo, B. R., Ocholla, H., Nkya, S. W., Kimani, E., Williams, T., Makale, J., Liljander, A., Urban, B. C., Bull, P. C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014741 · Cited by 147
“As demonstrated in the field of pregnancy associated malaria, characterizing the molecular nature of these interactions is important in understanding the pathogenesis of the more severe forms of malaria, because it would potentially provide more information in the design of new methods of prevention and treatment [10,…”
MethodTHE USE OF ANTI-MALARIAL DRUGS TO PREVENT MALARIA IN THE POPULATION OF MALARIA-ENDEMIC AREAS
Greenwood, B. M. (2004) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.70.1 · Cited by 137
Barfod, L., Bernasconi, N. L., Dahlbäck, M., Jarrossay, D., Andersen, P. H., Salanti, A., Ofori, M. F., Turner, L., Resende, M., Nielsen, M. A., et al. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05503.x · Cited by 110
“The characteristics of the plasma IgG recognition pattern of VSAPAM and non-PAM-type VSA have been documented in detail elsewhere (Ricke et al., 2000; Staalsoe et al., 2001).”
Self-citationBeeson, J. G., Mann, E. J., Elliott, S. R., Lema, V. M., Tadesse, E., Molyneux, M. E., Brown, G. V., & Rogerson, S. J. (2004) · The Journal of Infectious Diseases · doi:10.1086/381186 · Cited by 109
“Others reported an inverse correlation between IgG binding and parasitemia among some MG but not among PG [15].”
BackgroundResultThe epidemiology and consequences of maternal malaria: a review of immunological basis
Okoko, B. J., Enwere, G. C., & Ota, M. O. C. (2003) · Acta Tropica · doi:10.1016/s0001-706x(03)00097-4 · Cited by 120
Uneke, C. J. (2007) · PubMed Central · Cited by 131
Cutts, J. C., Agius, P. A., Lin, Z., Powell, R., Moore, K. A., Draper, B. L., Simpson, J. A., & Fowkes, F. J. I. (2020) · BMC Medicine · doi:10.1186/s12916-019-1467-6 · Cited by 102
“Both parity and transmission intensity can influence the kinetics of antiVAR2CSA antibody responses during pregnancy [35, 38, 39, 73].”
BackgroundThe Immunology and Pathogenesis of Malaria During Pregnancy
Beeson, J. G., & Duffy, P. E. (2005) · Current topics in microbiology and immunology · doi:10.1007/3-540-29967-x_6 · Cited by 105
HIV Impairs Opsonic Phagocytic Clearance of Pregnancy-Associated Malaria Parasites
Keen, J., Serghides, L., Ayi, K., Patel, S. N., Ayisi, J., van Eijk, A., Steketee, R., Udhayakumar, V., & Kain, K. C. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040181 · Cited by 92
“Protection against PAM is associated with plasma levels of VSA-PAM-specific IgG, which are generally low in PG women and nonpregnant individuals, and increase with increasing gravidity [16,17,21,29].”
BackgroundMalaria in Pregnancy: From Placental Infection to Its Abnormal Development and Damage
Chua, C. L. L., Khoo, S. K. M., Ong, J. L. E., Ramireddi, G. K., Yeo, T. W., & Teo, A. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.777343 · Cited by 103
Chootong, P., Ntumngia, F. B., VanBuskirk, K., Xainli, J., Cole‐Tobian, J. L., Campbell, C. O., Fraser, T. S., King, C. L., & Adams, J. H. (2009) · Infection and Immunity · doi:10.1128/iai.01036-09 · Cited by 93
“These discoveries for anti-DBP serological responses contrast with acquisition of immunity to the homologous VAR2CSA DBL domain, where there is a better correlation between development of protective immunity and repeated exposure (21).”
BackgroundThe Chondroitin Sulfate A-binding Site of the VAR2CSA Protein Involves Multiple N-terminal Domains
Dahlbäck, M., Jørgensen, L. M., Nielsen, M. A., Clausen, T. M., Ditlev, S. B., Resende, M., Pinto, V. V., Arnot, D. E., Theander, T. G., & Salanti, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.191510 · Cited by 85
Muthusamy, A., Achur, R. N., BHAVANANDAN, V. P., Fouda, G. G., Taylor, D. W., & Gowda, D. C. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63761-3 · Cited by 94
Self-citationDesigning a VAR2CSA-based vaccine to prevent placental malaria
Fried, M., & Duffy, P. E. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.011 · Cited by 86
Malaria, primigravidae, and antibodies: knowledge gained and future perspectives
Ataíde, R., Mayor, A. G., & Rogerson, S. J. (2014) · Trends in Parasitology · doi:10.1016/j.pt.2013.12.007 · Cited by 83
Hviid, L. (2010) · Human Vaccines · doi:10.4161/hv.6.1.9602 · Cited by 75
Self-citationMicroReview: The role of Plasmodium falciparum var genes in malaria in pregnancy
Rowe, J. A., & Kyes, S. A. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04256.x · Cited by 72
“The importance of placental sequestration was emphasized by the discovery that during pregnancy, malaria-infected women develop antibodies that inhibit binding of infected erythrocytes to CSA, and such antibodies are associated with protection against placental infection and low birthweight in subsequent pregnancies (…”
VAR2CSA and protective immunity against pregnancy-associated Plasmodium falciparum malaria
HVIID, L., & SALANTI, A. (2007) · Parasitology · doi:10.1017/s0031182007000121 · Cited by 69
“In any case, levels of VSAPAM-specific IgG at delivery correlate inversely with placental parasitaemia (Staalsoe et al. 2001), and direct and compelling evidence of the clinical im- portance of CSA adhesion-inhibitory as well as VSAPAM-specific IgG have recently become available (Duffy and Fried,…”
BackgroundSelf-citationChanging Trends in P. falciparum Burden, Immunity, and Disease in Pregnancy
Mayor, A., Bardají, A., Macete, E., Nhampossa, T., Fonseca, A. M., González, R., Maculuve, S., Cisteró, P., Rupérez, M., Campo, J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1406459 · Cited by 68
Tuikue Ndam, N. G., Fievet, N., Bertin, G., Cottrell, G., Gaye, A., & Deloron, P. (2004) · The Journal of Infectious Diseases · doi:10.1086/425521 · Cited by 67
“Other studies reported the ability of VSAPAP-specific IgG to interfere with in vitro adhesion to CSA [18, 20, 21, 25], but convincing evidence has not been fully documented.”
Self-citationHigh Avidity Antibodies to Full-Length VAR2CSA Correlate with Absence of Placental Malaria
Tutterrow, Y. L., Salanti, A., Avril, M., Smith, J. D., Pagano, I. S., Ako, S., Fogako, J., Leke, R. G. F., & Taylor, D. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040049 · Cited by 67
“Nonetheless, in previous studies Ab levels at delivery were not found to differ between PM(2) and PM women [13,33]; in fact, higher levels were often associated with active or chronic placental malaria [16,22].”
BackgroundSelf-citationMalaria immunity in infants: a special case of a general phenomenon?
Hviid, L., & Staalsøe, T. (2003) · Trends in Parasitology · doi:10.1016/j.pt.2003.11.009 · Cited by 76
Self-citationCreasey, A. M., Staalsøe, T., Raza, A., Arnot, D. E., & Rowe, J. A. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4767-4771.2003 · Cited by 73
“Antibodies directed against CSA-binding parasites correlate with increasing gravidity and increased protection from malaria pathology in women from regions where malaria is endemic, suggesting that development of a protective vaccine against pregnancy-associated malaria may be possible (18, 26, 41).”
Achur, R. N., Valiyaveettil, M., & Gowda, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211015200 · Cited by 68
Francis, S. E., Malkov, V. A., Oleinikov, A. V., Rossnagle, E., Wendler, J. P., Mutabingwa, T. K., Fried, M., & Duffy, P. E. (2007) · Infection and Immunity · doi:10.1128/iai.00635-07 · Cited by 65
“Serum immunoglobulin G (IgG) from multigravid women living in areas of endemicity has been shown to block adhesion of placental or CSA-selected parasites collected from different continents (18, 21, 54, 66).”
BackgroundLarsen, M. D., Lopez-Perez, M., Dickson, E. K., Ampomah, P., Ndam, N. T., Nouta, J., Koeleman, C. A. M., Ederveen, A. L. H., Mordmüller, B. G., Salanti, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26118-w · Cited by 67
Self-citationBarfod, L., Dobrilovic, T., Magistrado, P., Khunrae, P., Viwami, F., Bruun, J., Dahlbäck, M., Bernasconi, N. L., Fried, M., John, D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002390 · Cited by 62
Self-citationWilson, N. O., Ceesay, F. K., Obed, S. A., Adjei, A. A., Gyasi, R. K., Rodney, P., Ndjakani, Y., Anderson, W. A., Lucchi, N. W., & Stiles, J. K. (2011) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2011.10-0512 · Cited by 58
Megnekou, R., Staalsoe, T., Taylor, D. W., Leke, R., & Hviid, L. (2005) · Infection and Immunity · doi:10.1128/iai.73.7.4112-4118.2005 · Cited by 57
Self-citationHaase, R. N., Megnekou, R., Lundquist, M., Ofori, M. F., Hviid, L., & Staalsoe, T. (2006) · Infection and Immunity · doi:10.1128/iai.74.5.3035-3038.2006 · Cited by 52
Self-citationBeeson, J. G., Ndungu, F., Persson, K. E. M., Chesson, J. M., Kelly, G. L., Uyoga, S., Hallamore, S. L., Williams, T. N., Reeder, J. C., Brown, G. V., et al. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.22 · Cited by 52
Clinical and Parasitological Characteristics of Puerperal Malaria
Ramharter, M., Grobusch, M. P., Kießling, G., Adegnika, A. A., Möller, U., Agnandji, S. T. M., Kramer, M., Schwarz, N., Kun, J. F. J., Oyakhirome, S., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/427781 · Cited by 52
Pregnancy-associated malaria: Parasite binding, natural immunity and vaccine development
Gamain, B., Smith, J. D., Viebig, N. K., Gysin, J., & Scherf, A. (2006) · International Journal for Parasitology · doi:10.1016/j.ijpara.2006.11.011 · Cited by 53
“The fortunate discovery that in vitro cultured parasites selected for binding to CSA maintained similar antigenic and binding phenotypes to placental isolates (Robert et al., 1995; Rogerson et al., 1995; Scherf et al., 1998; Buffet et al., 1999; Staalsoe et al., 2001; Salanti et al., 2004) facilitated the identificati…”
InfluentialHviid, L. (2004) · Parasite Immunology · doi:10.1111/j.0141-9838.2004.00733.x · Cited by 51
Self-citationSerra‐Casas, E., Menéndez, C., Bardají, A., Quintó, L., Dobaño, C., Sigauque, B., Jiménez, A., Mandomando, I., Chauhan, V. S., Chitnis, C. E., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/648595 · Cited by 50
Bir, N., Yazdani, S. S., Avril, M., Layez, C., Gysin, J., & Chitnis, C. E. (2006) · Infection and Immunity · doi:10.1128/iai.00481-06 · Cited by 49
“falciparum isolates (4, 25) and CSA-binding laboratory strains (41, 51).”
BackgroundAmpomah, P., Stevenson, L., Ofori, M. F., Barfod, L., & Hviid, L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400325 · Cited by 45
“(30) reported that delivery levels of IgG specific for CSAadhering IEs declined substantially over the following 6 mo, in”
InfluentialSelf-citationMayor, A., Rovira-Vallbona, E., Machevo, S., Bassat, Q., Aguilar, R., Quintó, L., Jiménez, A., Sigauque, B., Dobaño, C., Kumar, S., et al. (2011) · Infection and Immunity · doi:10.1128/iai.01000-10 · Cited by 46
“, men exposed to malaria lack these antibodies [44, 50]) and parity dependent (i.”
BackgroundTrying to remember: immunological B cell memory to malaria
Hviid, L., Barfod, L. K., & Fowkes, F. J. I. (2015) · Trends in Parasitology · doi:10.1016/j.pt.2014.12.009 · Cited by 50
Self-citationMayor, A., Kumar, U., Bardají, A., Gupta, P., Jiménez, A., Hamad, A., Sigaúque, B., Singh, B., Quintó, L., Kumar, S., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit083 · Cited by 45
“falciparum [9, 20, 40] and that these heterogeneities need to be taken into account to assess the clinical impact of antibody responses against malaria during pregnancy.”
BackgroundA sub-family of common and highly conserved Plasmodium falciparum var genes
Salanti, A., Jensen, A. T. R., Zornig, H. D., Staalsoe, T., Joergensen, L., Nielsen, M. A., Khattab, A., Arnot, D. E., Klinkert, M. Q., Hviid, L., et al. (2002) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(02)00080-4 · Cited by 43
Self-citationIFN-gamma and TNF associated with severe falciparum malaria infection in Saudi pregnant women
Nasr, A., Allam, G. A., Hamid, O., & Al-Ghamdi, A. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-314 · Cited by 47
Aitken, E. H., Mbewe, B., Luntamo, M., Maleta, K., Kulmala, T., Friso, M., Fowkes, F. J. I., Beeson, J. G., Ashorn, P., & Rogerson, S. J. (2010) · The Journal of Infectious Diseases · doi:10.1086/651578 · Cited by 42
“Levels of pregnancy-specific IgG antibody have previously been noted to decrease in the postpartum period [20], and our study agrees with this finding, which is consistent with the hypothesis that exposure to these antigens is largely limited to pregnancy.”
ResultInfluentialMarinho, C. R. F., Neres, R., Epiphânio, S., Gonçalves, L. A., Catarino, M. B., & Penha‐Gonçalves, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005630 · Cited by 48
“The severe clinical manifestations are mainly restricted to the first and second pregnancies [16], when the levels of specific antibodies against placental parasite antigens are not high enough to confer protection [17,18].”
BackgroundIS MALARIAL PLACENTAL INFECTION RELATED TO PERIPHERAL INFECTION AT ANY TIME OF PREGNANCY?
COTTRELL, G., MARY, J.-Y., BARRO, D., & COT, M. (2005) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2005.73.1112 · Cited by 39
“of infected erythrocytes.(19) In our analysis, we pooled primi-”
Costa, F. T. M., Fusaï, T., Parzy, D., Sterkers, Y., Torrentino, M., Douki, J. L., Traoré, B., Petres, S., Scherf, A., & Gysin, J. (2003) · The Journal of Infectious Diseases · doi:10.1086/375800 · Cited by 41
Gamain, B., Smith, J. D., Avril, M., Baruch, D. I., Scherf, A., Gysin, J., & Miller, L. H. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04145.x · Cited by 40
“However, it is not unusual to detect CSA adhesion-inhibitory or surface-reactive antibodies in primigravidas as early as the second trimester (O’Neil-Dunne et al., 2001; Staalsoe et al., 2001), even though the women are infected at term.”
BackgroundBordbar, B., Ndam, N. T., Bigey, P., Doritchamou, J., Scherman, D., & Deloron, P. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.065 · Cited by 43
Self-citationGuitard, J., Cottrell, G., Magnouha, N. M., Salanti, A., Li, T., Sow, S., Deloron, P., & Ndam, N. T. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-10 · Cited by 39
“08), in line with other studies showing that primigravidae have lower levels of IgG against IE surface antigens than multigravidae [15].”
ResultSelf-citationPregnancy-associated Malaria and the Prospects for Syndrome-specific Antimalaria Vaccines
Smith, J. D., & Deitsch, K. W. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041974 · Cited by 39
“An additional puzzling finding is that pregnant women have antibodies that react with CSA-binding parasites as early as the second trimester (18, 19), yet are still infected at term.”
BackgroundTebo, A. E., Kremsner, P. G., Piper, K. P., & Luty, A. J. F. (2002) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2002.67.597 · Cited by 38
“falciparum infections in pregnant women.(4,32,33,48,49) The level of anti-VSA antibodies, furthermore, has been shown to correlate with adhesion inhibition, itself a surrogate marker of protection against P.”
BackgroundOfori, M. F., Staalsoe, T., Bam, V., Lundquist, M., David, K. P., Browne, E. N. L., Akanmori, B. D., & Hviid, L. (2003) · Infection and Immunity · doi:10.1128/iai.71.3.1584-1586.2003 · Cited by 37
Self-citationStaalsoe, T., Shulman, C. E., Dorman, E. K., Kawuondo, K., Marsh, K., & Hviid, L. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5027-5030.2004 · Cited by 34
Self-citationCot, M., & Deloron, P. (2003) · British Medical Bulletin · doi:10.1093/bmb/ldg003 · Cited by 33
Self-citationThe case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria
Hviid, L. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.113 · Cited by 34
Self-citationSotimehin, S., Runsewe-Abiodun, T. I., Oladapo, O. T., Njokanma, O. F., & Olanrewaju, D. M. (2008) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fmn016 · Cited by 36
Dechavanne, S., Srivastava, A., Gangnard, S., Nunes-Silva, S., Dechavanne, C., Fievet, N., Deloron, P., Chêne, A., & Gamain, B. (2015) · Infection and Immunity · doi:10.1128/iai.03116-14 · Cited by 31
Self-citationAgbor-Enoh, S. T., Achur, R. N., Valiyaveettil, M., Leke, R., Taylor, D. W., & Gowda, D. C. (2003) · Infection and Immunity · doi:10.1128/iai.71.5.2455-2461.2003 · Cited by 34
“Pregnant women produce C4S-IRBC adhesioninhibitory antibodies in a gestational age-dependent manner (32, 38), and they either lack or have very low levels of antibodies at conception and produce antibodies in the second trimester.”
BackgroundSelf-citationMaternal vitamin A supplementation and immunity to malaria in pregnancy in Ghanaian primigravids
Cox, S. E., Staalsoe, T., Arthur, P., Bulmer, J. N., Tagbor, H., Hviid, L., Frost, C., Riley, E. M., & Kirkwood, B. R. (2005) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2005.01515.x · Cited by 35
“Parity-dependent development of immunity to pregnancy-associated malaria has been linked to acquisition – during first and second pregnancies – of anti-VSA antibodies that specifically block pRBC sequestration in the placenta (Fried et al. 1998; Staalsoe et al. 2001).”
BackgroundMethodResultInfluentialSelf-citationFiévet, N., Tami, G., Maubert, B., Moussa, M., Shaw, I. K., Cot, M., Holder, A. A., Chaouat, G., & Deloron, P. (2002) · Malaria Journal · doi:10.1186/1475-2875-1-16 · Cited by 39
“Moreover, antibodies directed against CSA-adhering parasites and acquired during an infected pregnancy inhibited the cytoadherence of CSA-adhering parasites to human syncytiotrophoblasts [22].”
BackgroundSelf-citationPre-clinical and clinical development of the first placental malaria vaccine
Pehrson, C., Salanti, A., Theander, T. G., & Nielsen, M. A. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1322512 · Cited by 34
Ampomah, P., Stevenson, L., Ofori, M. F., Barfod, L. K., & Hviid, L. (2014) · Infection and Immunity · doi:10.1128/iai.01514-13 · Cited by 36
Self-citationPerraut, R., Marrama, L., Diouf, B., Fontenille, D., Tall, A., Sokhna, C., Trape, J., Garraud, O., & Mercereau‐Puijalon, O. (2003) · The Journal of Infectious Diseases · doi:10.1086/379838 · Cited by 31
“the infected erythrocyte surface have been shown to be associated with protection against clinical malaria in African children [2, 3, 15] and against placental infection during pregnancy [50, 51].”
BackgroundMalaria vaccine clinical trials: what's on the horizon
Moreno, A., & Joyner, C. J. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.06.008 · Cited by 31
Cox, S. E., Staalsøe, T., Arthur, P., Bulmer, J. N., Hviid, L., Yeboah‐Antwi, K., Kirkwood, B. R., & Riley, E. M. (2005) · Infection and Immunity · doi:10.1128/iai.73.5.2841-2847.2005 · Cited by 33
“In contrast, the mean levels of IgG to the non-CSA adherent lines decreased during pregnancy, reaching statistical significance for the Busua parasite line, and also for the Busua line they decreased significantly further postpartum, a finding similar to previous observations for a Cameroonian cohort (31).”
BackgroundMethodResultSelf-citationFried, M., Kurtis, J. D., Swihart, B., Morrison, R., Pond-Tor, S., Barry, A., Sidibe, Y., Keita, S., Mahamar, A., Andemel, N., et al. (2018) · Malaria Journal · doi:10.1186/s12936-018-2258-9 · Cited by 30
“Changes in IgG levels during pregnancy Previous studies reported that antibody reactivities to the IE surface of CSA-binding parasites in primigravidae and to recombinant VAR2CSA in both primigravidae and multigravidae declined after pregnancy [25, 26].”
Andrews, K. T., Pirrit, L. A., Przyborski, J. M., Sanchez, C. P., Sterkers, Y., Ricken, S., Wickert, H., Lépolard, C., Avril, M., Scherf, A., et al. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03595.x · Cited by 30
Costa, F. T. M., Avril, M., Nogueira, P. A., & Gysin, J. (2006) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006001200003 · Cited by 37
“Primigravidae have a much higher susceptibility to maternal malaria than multigravidae, because the antibodies acquired after multiple pregnancies are associated with a reduction in the number of IE in the placenta (34).”
BackgroundChan, J.-A., Howell, K. B., Langer, C., Maier, A. G., Hasang, W., Rogerson, S. J., Petter, M., Chesson, J. M., Stanisic, D. I., Duffy, M. F., et al. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2267-1 · Cited by 30
“Reflecting previous exposure to CSA-binding isolates that primarily expresses var2csa [56], multigravid (MG) women generally have a higher prevalence of antibodies to placental isolates compared to primigravid (PG) women or men [31, 34, 57] and the findings in this study are consistent with that.”
ResultMonocyte Activation and T Cell Inhibition inPlasmodium falciparum–Infected Placenta
Diouf, I., Fiévet, N., Doucouré, S., Ngom, M., Gaye, A., Dumont, A., Ndao, C. T., Hesran, J. L., Chaouat, G., & Deloron, P. (2004) · The Journal of Infectious Diseases · doi:10.1086/420791 · Cited by 30
Self-citationBabakhanyan, A., Fang, R., Wey, A. R., Salanti, A., Sama, G., Efundem, C., LEKE, R. J. I., Chen, J. J., Leke, R. G. F., & Taylor, D. W. (2015) · Malaria Journal · doi:10.1186/s12936-015-1023-6 · Cited by 28
“Over successive pregnancies, women produce Ab to VAR2CSA that inhibit the binding of IE to CSA in vitro [3, 4], reduce maternal anaemia [5], lower placental parasitaemia at delivery [6, 7], increase the length of gestation [8], and improve infant birth weight [8].”
BackgroundSelf-citationMaestre, A., & Carmona‐Fonseca, J. (2014) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.3777 · Cited by 29
“Therefore, in Africa, immunity to CSA-binding parasites appears to be gender specific (thus men exposed to malaria lack these antibodies) [116,117] and parity related (thus antibodies increase during successive pregnancies) [111,116,117].”
BackgroundBrustoski, K., Kramer, M., Möller, U., Kremsner, P. G., & Luty, A. J. F. (2005) · Infection and Immunity · doi:10.1128/iai.73.12.7988-7995.2005 · Cited by 28
“with protection against pregnancy-associated malaria (25, 31).”
Babakhanyan, A., Leke, R. G. F., Salanti, A., Bobbili, N., Gwanmesia, P., Leke, R. J. I., Quakyi, I. A., Chen, J. J., & Taylor, D. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088173 · Cited by 26
“In malaria endemic areas, pregnant women produce antibodies (Ab) to VAR2CSA that inhibit the binding of IE to CSA in vitro [7,8], reduce maternal anemia [9], lower placental parasitemia at delivery [10,11], increase the length of gestation [12], and improve infant birth weight [12].”
BackgroundSelf-citationEisen, D. P., Wang, L., Jouin, H., Murhandarwati, E. E. H., Black, C. G., Mercereau‐Puijalon, O., & Coppel, R. L. (2007) · Malaria Journal · doi:10.1186/1475-2875-6-86 · Cited by 26
“Antibodies to chondroitin sulphate A-binding variant surface antigens have also been shown to be short-lived in women with pregnancy associated malaria but their presence correlates with protection against infection of the placenta [30].”
BackgroundMuthusamy, A., Achur, R. N., Valiyaveettil, M., Madhunapantula, S. V., Kakizaki, I., Bhavanandan, V. P., & Gowda, C. D. (2004) · Glycobiology · doi:10.1093/glycob/cwh077 · Cited by 28
“…C4S structural requirements for adhesion, and the characteristics of the parasite adhesive protein (Achur et al., 2000; Alkhalil et al., 2000; Baruch, 1999; Fried et al., 1998; Gamain et al., 2001; O'Neil-Dunne et al., 2001; Pouvelle et al., 1998; Smith et al., 2000; Staalsoe et al., 2001).”
BackgroundMethodDecreasing Malaria Prevalence and Its Potential Consequences for Immunity in Pregnant Women
Teo, A., Hasang, W., Randall, L. M., Feng, G., Bell, L., Unger, H., Langer, C., Beeson, J. G., Siba, P. M., Mueller, I., et al. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu264 · Cited by 25
“Development of these antibodies is influenced by transmission intensity, human immunodeficiency virus (HIV) infection, and the use of malaria-prevention strategies, including insecticide-treated bed nets (ITNs) [11–14].”
BackgroundMakobongo, M. O., Keegan, B. P., Long, C. A., & Miller, L. H. (2006) · The Journal of Infectious Diseases · doi:10.1086/500150 · Cited by 25
Lopez-Perez, M., Larsen, M. D., Bayarri-Olmos, R., Ampomah, P., Stevenson, L., Arévalo-Herrera, M., Herrera, S., & Hviid, L. (2018) · Infection and Immunity · doi:10.1128/iai.00136-18 · Cited by 24
Self-citationCross-Reactive Immune Responses as Primary Drivers of Malaria Chronicity
Klein, E. Y., Graham, A. L., Llinás, M., & Levin, S. A. (2013) · Infection and Immunity · doi:10.1128/iai.00958-13 · Cited by 24
Baruch, D. I., Gamain, B., & Miller, L. H. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4536-4543.2003 · Cited by 24
“terial glutathione S-transferase (GST) and GST-r179 (MC rC1-2 [1-179]) were”
BackgroundFiévet, N., Hesran, J. L., Cottrell, G., Doucouré, S., Diouf, I., Ndiaye, J. L., Bertin, G. I., Gaye, O., Sow, S., & Deloron, P. (2006) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2006.02.006 · Cited by 24
Self-citationA brief review on features of falciparum malaria during pregnancy
Manirakiza, A., Serdouma, E., Ngbalé, R. N., Moussa, S., Gondjé, S., Degana, R. M., Bata, G. G. B., Moyen, J. M., Delmont, J. P., Grésenguet, G., et al. (2017) · Journal of Public Health in Africa · doi:10.4081/jphia.2017.668 · Cited by 25
The Surface of thePlasmodium falciparum-infected Erythrocyte
Smith, J. D., & Craig, A. G. (2005) · Current Issues in Molecular Biology · doi:10.21775/cimb.007.081 · Cited by 24
Progress and new horizons toward a VAR2CSA-based placental malaria vaccine
Doritchamou, J., Suurbaar, J., & Ndam, N. T. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1878029 · Cited by 21
“falciparum and they correlate with more favorable pregnancy outcomes [4,40,41].”
BackgroundAgerbæk, M. Ø., Pereira, M. A., Clausen, T. M., Pehrson, C., Oo, H. Z., Spliid, C. B., Rich, J. R., Fung, V., Nkrumah, F., Neequaye, J. E., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30575 · Cited by 20
Metadata
- Authors
- Staalsoe, T., Megnekou, R., Fievét, N., Ricke, C. H., Zornig, H. D., Leke, R., Taylor, D. W., Deloron, P., & Hviid, L.
- Affiliations
- University of Copenhagen (DK)
- Université de Yaoundé I (CM)
- Georgetown University (US)
- Inserm (FR)
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-09
- Volume
- 184
- Issue
- 5
- Pages
- 618-626
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2132618017
- Cited by
- 161
- References
- 25
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 7 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 5 · 2017: 6 · 2016: 5 · 2015: 7 · 2014: 9 · 2013: 5 · 2012: 5
- FWCI
- 16.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI35839, U01AI035839)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Keywords
- malaria in pregnancy, Plasmodium falciparum, variant surface antigens, chondroitin sulfate A, antibody acquisition, antibody waning, parity, endemicity, parasite adhesion, malaria vaccination, placental infection
- MeSH terms
- Animals, Antibodies, Protozoan, Antigens, Protozoan, Antimalarials, Cell Adhesion, Chloroquine, Chondroitin Sulfates, Erythrocytes, Female, Humans, Placenta Diseases, Plasmodium falciparum, Pregnancy, Pregnancy Complications, Parasitic, Malaria, Falciparum, Parasitemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.